1. Home
  2. RYN vs GKOS Comparison

RYN vs GKOS Comparison

Compare RYN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$19.56

Market Cap

6.1B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$101.04

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
GKOS
Founded
1926
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
RYN
GKOS
Price
$19.56
$101.04
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$26.00
$133.07
AVG Volume (30 Days)
3.2M
577.7K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
12.51%
N/A
EPS Growth
26.78
N/A
EPS
3.03
N/A
Revenue
$484,485,000.00
$507,442,000.00
Revenue This Year
$214.96
$23.34
Revenue Next Year
$10.35
$27.46
P/E Ratio
$6.57
N/A
Revenue Growth
N/A
32.33
52 Week Low
$19.56
$73.16
52 Week High
$28.14
$130.23

Technical Indicators

Market Signals
Indicator
RYN
GKOS
Relative Strength Index (RSI) 27.84 37.84
Support Level N/A $94.92
Resistance Level $22.53 $104.66
Average True Range (ATR) 0.52 4.02
MACD -0.12 -0.71
Stochastic Oscillator 2.20 22.45

Price Performance

Historical Comparison
RYN
GKOS

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: